Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation

Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Allergy and Clinical Immunology - Volume 139, Issue 5, May 2017, Pages 1629-1640.e2

Katja G. MD, PhD, Louis-Marie PhD, Fayhan MD, Ashley MD, Qi PhD, Hao PhD, Clement PhD, Troy R. MD, PhD, Sergio D. MD, PhD, Thomas A. MD, Luigi D. MD, Imelda C. MD, Lisa R. MD, Talal A. MD, MSc,